-
By John K. Waters
The global market for nanotechnology in medical devices is set for significant growth, driven by technological advancements, increasing healthcare demands, and a shift towards precision medicine. According to a newly released report by Research And Markets, the sector was valued at $3.4 billion in 2024 and is projected to reach $4.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.4%.
Read More
-
By John K. Waters
GE HealthCare is expanding its artificial intelligence (AI) partnership with Nvidia to develop autonomous X-ray and ultrasound systems, aiming to alleviate radiology staff shortages and enhance imaging capabilities.
Read More
-
More than 80 percent of healthcare professionals surveyed for a recent Nvidia report credited AI use for helping increase their revenues.
Read More
-
An AI system designed for medical reasoning has advanced beyond diagnosis to support disease treatment and management, according to researchers.
Read More
-
By John K. Waters
The global artificial kidney market is projected to grow at a compound annual growth rate of approximately 13% by 2032, driven by increasing cases of chronic kidney disease (CKD) and end-stage renal disease (ESRD), according to a new report by DelveInsight Business Research.
Read More
-
By John K. Waters
FAIR Health, an independent nonprofit that collects data for and manages one of the nation's largest databases of privately billed health insurance claims, has launched a shared decision-making tool for Alzheimer's disease that features clinical information for self-care and drug therapy options, as well as related cost information.
Read More
-
By John K. Waters
NeuralCure AI, a healthcare technology company specializing in artificial intelligence-driven diagnostics and treatment simulations, announced Tuesday the launch of a new platform aimed at expediting medical research and personalized treatment development. The company also opened a fundraising round to expand its capabilities and partnerships.
Read More
-
By John K. Waters
Akso Health Group announced that it has integrated DeepSeek's artificial intelligence technology into its medical consultation and diagnostic processes. The company aims to improve diagnostic accuracy, streamline healthcare resource allocation, and enhance efficiency in patient care.
Read More
-
By John K. Waters
Rackspace Technology announces a partnership with Dubai Health to explore the creation of a Healthcare Digital Hub.
Read More
-
By John K. Waters
Rohde & Schwarz has unveil new PC-based oscilloscope software designed to extend the functionality of its MXO series oscilloscopes.
Read More
-
By John K. Waters
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Irish startup CergenX's advanced AI-powered "Wave" device for neonatal brain monitoring. The company has also been accepted into the FDA's Total Product Lifecycle Advisory Program (TAP), positioning the Wave device for accelerated development and regulatory review.
Read More
-
By John K. Waters
Haptikos, a startup specializing in lifelike touch-based spatial technology, introduces its flagship hand exoskeleton, bringing realism to virtual interactions with haptic responses from extended reality devices.
Read More
-
By John K. Waters
Percipio Health, a Plano, Texas-based startup specializing in population health monitoring, has officially launched with a new platform that promises to lower costs and improve care outcomes using artificial intelligence and smartphone-based technology.
Read More
-
By John K. Waters
Health-care technology company Waystar announced on Monday the launch of a new generative AI solution aimed at addressing the growing financial and administrative burden of health insurance claim denials.
Read More
-
By John K. Waters
GE HealthCare has signed a landmark seven-year agreement with Sutter Health, a nonprofit healthcare provider based in Sacramento, California, to deliver cutting-edge AI-powered medical imaging technology and digital solutions across its network.
Read More
-
By John K. Waters
Nvidia announced a series of groundbreaking collaborations at the J.P. Morgan Healthcare Conference in San Francisco on Monday. These partnerships, spanning healthcare, life sciences, and biopharma, aim to accelerate the adoption and scalability of AI models across the sector, driving advancements in diagnostics, drug discovery, and precision medicine.
Read More